Rossari Biotech share news and announcements

NSE: ROSSARIBSE: 543213Chemicals & PetrochemicalsSmall Cap

₹414.70₹12.60 (2.95%)BSE ₹414.80

Share price at the NSE close on 23 Oct 2026. Previous close ₹427.30.

52-week range of traded prices to 23 Oct 2026

₹375.00Low, 30 Mar 2026₹663.00High, 28 Oct 2025

Market cap: ₹2,297 Cr1,009th largest listed
P/E: 15.0
P/B: 1.6
Dividend yield: 0.12%
ROE: 11.5%
ROCE: 12.1%
Debt to equity: 0.26
Volume, NSE: 1,81,48259.5% delivered

Rossari Biotech board meetings

53 filed, newest first. Page 1 of 2.

Oct 2026
- 9 Oct · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 17/10/2026 ,inter alia, to consider and approve Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2026. (opens in a new tab)
Jul 2026
- 10 Jul · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 18/07/2026,inter alia, to consider and approve Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2026. (opens in a new tab)
May 2026
- 27 May · Board meeting
  Outcome of Board Meeting held on May 27, 2026. (opens in a new tab)
Apr 2026
- 18 Apr · Board meeting
  Meeting of Board of Directors of the Company is scheduled on 27/04/2026, inter alia, to consider and approve, 1. Audited Financial Statements and Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended March 31, 2026. 2. recommend payment of Final Dividend, if any, for the Financial Year ended March 31, 2026. (opens in a new tab)
Jan 2026
- 9 Jan · Board meeting
  Board Meeting to be held on January 17, 2026, to inter-alia, to consider and approve the Unaudited Financial results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2025. (opens in a new tab)
Dec 2025
- 18 Dec · Board meeting
  Board of Directors have inter alia approved Incorporation of wholly owned subsidiary in Republic of Singapore and other matters. (opens in a new tab)
Oct 2025
- 7 Oct · Board meeting
  Board Meeting to be held on 15th October 2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the quarter and half year ended September 30, 2025. (opens in a new tab)
Jul 2025
- 11 Jul · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 19/07/2025,inter alia, to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2025. (opens in a new tab)
Apr 2025
- 17 Apr · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 25/04/2025,inter alia, to consider and approve1. Audited Financial Statements and Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended March 31, 2025.2. recommend payment of Final Dividend, if any, for the Financial Year ended March 31, 2025. (opens in a new tab)
Jan 2025
- 21 Jan · Board meeting
  Outcome of Board Meeting held on January 21, 2025. (opens in a new tab)
- 13 Jan · Board meeting
  Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31, 2024. (opens in a new tab)
Nov 2024
- 30 Nov · Board meeting
  Outcome of Board Meeting held on November 30, 2024. (opens in a new tab)
Oct 2024
- 19 Oct · Board meeting
  Board meeting held on October 19, 2024. (opens in a new tab)
- 19 Oct · Board meeting
  Board of Directors have inter alia approved the Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year ended September 30, 2024 and other Matters. (opens in a new tab)
- 11 Oct · Board meeting
  To consider and approve the Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30, 2024 (opens in a new tab)
Jul 2024
- 20 Jul · Board meeting
  Board of Directors have inter alia approved the Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2024. (opens in a new tab)
- 12 Jul · Board meeting
  Board Meeting to be held on 20-July-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the quarter ended June 30 2024 (opens in a new tab)
Apr 2024
- 20 Apr · Board meeting
  To consider and approve the financial results for the period ended March 31, 2024 and dividend (opens in a new tab)
- 6 Apr · Board meeting
  Board of Directors have inter alia approved Incorporation of wholly owned subsidiary in Dubai, United Arab Emirates and Appointment of Mr. Sunil V as Chief Human Resource Officer and other matters. (opens in a new tab)
Jan 2024
- 20 Jan · Board meeting
  Board meeting held on January 20, 2024 (Revised). (opens in a new tab)
- 20 Jan · Board meeting
  Board meeting held on January 20, 2024. (opens in a new tab)
- 12 Jan · Board meeting
  Meeting of the Board of Directors of the Company is scheduled to be held on January 20, 2024 inter alia, to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2023. (opens in a new tab)
Oct 2023
- 21 Oct · Board meeting
  Board meeting held on October 21, 2023. (opens in a new tab)
- 13 Oct · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on October 21, 2023, inter alia, to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and half ended September 30, 2023. (opens in a new tab)
Jul 2023
- 29 Jul · Board meeting
  Board of Directors have Inter alia approved Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2023 of the Financial Year 2023-24 and other matters. (opens in a new tab)
- 21 Jul · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 29/07/2023 ,inter alia, to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2023. (opens in a new tab)
May 2023
- 5 May · Board meeting
  Outcome of Board Meeting held on Friday, May 05, 2023 in compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (opens in a new tab)
Apr 2023
- 22 Apr · Board meeting
  Meeting of the Board of Directors of the Company is scheduled to be held on 29/04/2023 ,inter alia, to consider and approve Audited Financial Statements and Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2023 and Dividend (if any) (opens in a new tab)
Feb 2023
- 4 Feb · Board meeting
  Board has inter alia approved Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2022 for the Financial Year 2022-23 and other matters. (opens in a new tab)
Jan 2023
- 25 Jan · Board meeting
  Board Meeting Intimation for inter alia to approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2022 (opens in a new tab)
Nov 2022
- 5 Nov · Board meeting
  Board has inter alia approved Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2022 for the Financial Year 2022-23 and other matters. (opens in a new tab)
Oct 2022
- 28 Oct · Board meeting
  Board Meeting to be held on November 05, 2022 to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2022. (opens in a new tab)
Aug 2022
- 6 Aug · Board meeting
  Board has inter alia approved Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2022 of the Financial Year 2022-23. (opens in a new tab)
Jul 2022
- 30 Jul · Board meeting
  Board Meeting to be held on August 06, 2022, inter alia, to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2022. (opens in a new tab)
May 2022
- 19 May · Board meeting
  Board of Directors have Inter alia approved Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2022 of the financial year 2021-22 and other matters. (opens in a new tab)
- 11 May · Board meeting
  Board Meeting to be held on 19-May-2022 to consider financial statements for the period ended March 2022 and Dividend (opens in a new tab)
Feb 2022
- 14 Feb · Board meeting
  Board has inter alia approved Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2021 of the Financial Year 2021-22. (opens in a new tab)
- 8 Feb · Board meeting
  Board Meeting intimation to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2021 (opens in a new tab)
Jan 2022
- 21 Jan · Board meeting
  Board Meeting intimation to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2021 (opens in a new tab)
  Not held on this date
Oct 2021
- 30 Oct · Board meeting
  Board meeting held on October 30, 2021. (opens in a new tab)
- 22 Oct · Board meeting
  Board Meeting intimation to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter ended September 30, 2021. (opens in a new tab)
Jul 2021
- 30 Jul · Board meeting
  Board meeting held on July 30, 2021. (opens in a new tab)
- 22 Jul · Board meeting
  Inter alia, to consider and approve the Un-audited financial results (Standalone and Consolidated) for the period ended Jun 30, 2021 (opens in a new tab)
May 2021
- 14 May · Board meeting
  Board meeting held on May 14, 2021. (opens in a new tab)
- 6 May · Board meeting
  Meeting Board of Directors of the Company is scheduled to be held on Friday, May 14, 2021,inter alia, To consider and approve the financial results for the period ended March 31, 2021 and recommend payment of Final Dividend, if any, for the financial year ended March 31, 2021. (opens in a new tab)
Mar 2021
- 23 Mar · Board meeting
  Board meeting held on March 23, 2021 inter alia for Issue and allotment of up to 30,12,046 equity shares of the Company by way of Preferential Allotment (opens in a new tab)
- 18 Mar · Board meeting
  To consider Fund Raising (opens in a new tab)
Jan 2021
- 23 Jan · Board meeting
  Outcome of Board meeting held on January 23, 2021. (opens in a new tab)
- 15 Jan · Board meeting
  To consider and approve the financial results for the quarter and nine months ended December 31, 2020 (opens in a new tab)
Oct 2020
- 24 Oct · Board meeting
  Board meeting held on October 24, 2020. (opens in a new tab)

Rossari Biotech board meetings

Oct 2026

Jul 2026

May 2026

Apr 2026

Jan 2026

Dec 2025

Oct 2025

Jul 2025

Apr 2025

Jan 2025

Nov 2024

Oct 2024

Jul 2024

Apr 2024

Jan 2024

Oct 2023

Jul 2023

May 2023

Apr 2023

Feb 2023

Jan 2023

Nov 2022

Oct 2022

Aug 2022

Jul 2022

May 2022

Feb 2022

Jan 2022

Oct 2021

Jul 2021

May 2021

Mar 2021

Jan 2021

Oct 2020